Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Viral load news

Show

From To
Q&A: Understanding persistent low-level viremia in people with HIV

Persistent low-level viremia among people living with HIV who are adhering to treatment is a challenging issue for clinicians, and there is not much guidance available.

Published
19 March 2019
From
Healio
More than 1 year to HIV control raises failure risk almost 10-fold

Failure to reach an undetectable viral load in the first year of antiretroviral therapy (ART) led to nearly a 10-fold higher risk of subsequent virologic failure in a 17,000-person North American analysis [1]. Taking more than 1 year to control HIV did not confer a higher risk of low-level viremia or viral blips in this 6-year study.

Published
15 March 2019
From
NATAP
Detectable HIV Despite Treatment? Clonal Expansion Could Be The Culprit

In a study of people with a low but detectable viral load despite adherence to treatment, infected cells were apparently cloning themselves.

Published
14 March 2019
From
Poz
When Undetectable Is Unachievable: Study Offers Insights into HIV Persistence

Rarely, people living with HIV are unable to maintain an undetectable viral load despite strict adherence to daily ART. New NIAID-funded research suggests that this sometimes can occur when a single cell from the HIV reservoir—the population of long-lived HIV-infected cells that ART cannot eradicate—multiplies to create many identical cells that produce enough virus to be detected by standard viral load tests.

Published
11 March 2019
From
National Institute of Allergy and Infectious Diseases
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
Point-of-care viral load testing improves treatment outcomes and retention in care

Same-day provision of results from a point-of-care viral load test – rather than waiting weeks for laboratory results to be collected – resulted in a 14% improvement

Published
05 March 2019
By
Roger Pebody
Viral load monitoring motivates HIV treatment adherence in eSwatini

The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

Published
24 February 2019
From
AVERT
For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?

Do the guidelines for laboratory monitoring still make sense when our HIV treatments have become so safe and effective?

Published
29 January 2019
From
NEJM Journal Watch
Uganda: Financial incentives do not boost HIV viral suppression rate

Financial incentives had no effect on viral suppression among HIV-positive adults in Uganda, according to a recent study. Researchers said these findings suggest a need for better interventions to promote the achievement of viral suppression.

Published
25 January 2019
From
Healio
How do we define “undetectable” in HIV prevention?

In real life, whether your viral load is 50, 100, or 200 copies may not matter as much as how long your virus has been suppressed.

Published
23 January 2019
From
BETA blog
← First12345...18Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.